Abstract:Targeted metabolomics with absolute quantification is widely applied in biomarker identification and drug screening. However, due to the complexity of biological matrix and trace amount of metabolites in plasma, simultaneous quantification of highly polar metabolites in plasma with broad coverage in short time is still challenging. Herein, we proposed a nanoconfined liquid phase nanoextraction (NLPNE) combined with in-fiber derivatization (IFD) strategy that enabled simultaneous quantification of seventy amino-containing analytes in plasma, including amines, nucleosides and their metabolites. Methanol−water (2:1, v/v) was selected as nanoconfined solvent (NCS) to quickly extract highly polar analytes based on the nanoconfinement effect, followed by IFD process directly performed by adding the derivatization reagent benzoyl chloride (BzCl) within 5 min. Besides saving time, this combination strategy was environment-friendly with little organic solvent consumption and cost-effective by using reusable carbon nanofibers. Furthermore, the sensitivity was increased up to 4.92-fold compared with protein precipitation (PP) based conventional derivatization method. Key factors that affected derivatization efficiency including the derivatization time, the amount of derivatization reagent, desorption solution and CNFs, were optimized by response surface methodology (RSM). After systematical method validation, this methodology was applied to determine the multi-metabolites index in plasma of lung cancer using an integrated data processing workflow. Then lung cancer diagnosis model was established through binary logistic regression analysis to make a reference for quick lung cancer screening clinically. Taken together, the NLPNE-IFD LC-MS/MS method for targeted metabolomics enables simultaneous quantification of seventy amino-containing analytes with advantages of broad coverage, high sensitivity, time- and solvent-saving, which could be used on cancer diagnosis clinically.

An in Vitro Liver Model on Microfluidic Device for Analysis of Capecitabine Metabolite Using Mass Spectrometer As Detector

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

Optimization of Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous Determination of Capilliposide B and Its Active Metabolite in Rat Urine and Feces: Overcoming Nonspecific Binding.

Analysis of Cytotoxic Effects of Chemotherapeutic Agents for Gastrointestinal Cancer with Cell-based Impedance Biosensor

Imitation of drug metabolism in human liver and cytotoxicity assay using a microfluidic device coupled to mass spectrometric detection.

Imitation of drug metabolism in cell co-culture microcapsule model using a microfluidic chip platform coupled to mass spectrometry

Qualitative and quantitative analysis of tumor cell metabolism via stable isotope labeling assisted microfluidic chip electrospray ionization mass spectrometry.

Evaluation of the Absorption of Methotrexate on Cells and Its Cytotoxicity Assay by Using an Integrated Microfluidic Device Coupled to A Mass Spectrometer

Microfluidic Cell Culture and Metabolism Detection with Electrospray Ionization Quadrupole Time-Of-Flight Mass Spectrometer

Cell-based assays in combination with ultra-high performance liquid chromatography-quadrupole time of flight tandem mass spectrometry for screening bioactive capilliposide C metabolites generated by rat intestinal microflora

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Lab-on-a-Chip for Anticancer Drug Screening Using Quantum Dots Probe Based Apoptosis Assay.

Simultaneous Determination of Capilliposide B and Capilliposide C in Rat Plasma by Lc-Ms/Ms and Its Application to A Pk Study

Integrating Sensitive Quantification of Hepatic Metabolic Functions by Capillary Electrophoresis with Laser-Induced Fluorescence Detection

Advanced Liver-on-a-Chip Model for Evaluating Drug Metabolism and Hepatotoxicity

Serum Metabolic Fingerprints on Bowl-Shaped Submicroreactor Chip for Chemotherapy Monitoring

Integrated microfluidic system for cell co-culture and simulation of drug metabolism

Deciphering the metabolic profile and anti-colorectal cancer mechanism of Capilliposide A using ultra performance liquid chromatography mass spectrometry combined with non-targeted metabolomics studies

Physiologically Based Pharmacokinetic Modeling for Prediction of 5-FU Pharmacokinetics in Cancer Patients with Hepatic Impairment after 5-FU and Capecitabine Administration.

A UPLC-MS/MS method for quantification of a novel doxorubicin conjugation prodrug in tumor cells

Nanoconfined liquid phase nanoextraction combined with in-fiber derivatization for simultaneous quantification of seventy amino-containing metabolites in plasma by LC-MS/MS: Exploration of lung cancer screening model